Abstract
The transplantation of progenitor cells is a promising new approach for the treatment of gliomas. Marrow stromal cells (MSC) are possible candidates for such a cell-based therapy, since they are readily and autologously available and show an extensive tropism to gliomas in vitro and in vivo. However, the signals that guide the MSC are still poorly understood. In this study, we show that gliomas have the capacity to actively attract MSC by secreting a multitude of angiogenic cytokines. We demonstrate that interleukin-8 (IL-8), transforming growth factor-ß1 (TGF-ß1) and neurotrophin-3 (NT-3) contribute to this glioma-directed tropism of human MSC. Together with the finding that vascular endothelial growth factor (VEGF) is another MSC-attracting factor secreted by glioma cells, these data support the hypothesis that gliomas use their angiogenic pathways to recruit mesenchymal progenitor cells.
Similar content being viewed by others
References
Sathornsumetee S, Rich J (2006) New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 6:1087–1104
Aboody K, Brown A, Rainov N, Bower K, Liu S, Yang W, Small J, Herrlinger U, Ourednik V, Black P, Breakefield X, Snyder E (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97:12846–12851
Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn J, Goldbrunner R (2006) Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol 199:301–310
Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang F (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307–3318
Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155–1164
Kargiotis O, Rao J, Kyritsis A (2006) Mechanisms of angiogenesis in gliomas. J Neurooncol 78:281–293
Hamel W, Westphal M, Szönyi E, Escandón E, Nikolics K (1993) Neurotrophin gene expression by cell lines derived from human gliomas. J Neurosci Res 34:147–157
Donovan M, Miranda R, Kraemer R, McCaffrey T, Tessarollo L, Mahadeo D, Sharif S, Kaplan D, Tsoulfas P, Parada L (1995) Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 147:309–324
Weis J, Schönrock L, Züchner S, Lie D, Sure U, Schul C, Stögbauer F, Ringelstein E, Halfter H (1999) CNTF and its receptor subunits in human gliomas. J Neurooncol 44:243–253
Wiesenhofer B, Stockhammer G, Kostron H, Maier H, Hinterhuber H, Humpel C (2000) Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas. Acta Neuropathol (Berl) 99:131–137
Yamauchi J, Chan J, Shooter E (2003) Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway. Proc Natl Acad Sci U S A 100:14421–14426
Padovan C, Jahn K, Birnbaum T, Reich P, Sostak P, Strupp M, Straube A (2003) Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant 12:839–848
Tabatabai G, Bähr O, Möhle R, Eyüpoglu I, Boehmler A, Wischhusen J, Rieger J, Blümcke I, Weller M, Wick W (2005) Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain 128:2200–2211
Von Lüttichau I, Notohamiprodjo M, Wechselberger A, Peters C, Henger A, Seliger C, Djafarzadeh R, Huss R, Nelson P (2005) Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev 14:329–336
Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek A, Silberstein L (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030–1041
Sordi V, Malosio M, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone B, Bertuzzi F, Zerbini G, Allavena P, Bonifacio E, Piemonti L (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419–427
Son B, Marquez-Curtis L, Kucia M, Wysoczynski M, Turner A, Ratajczak J, Ratajczak M, Janowska-Wieczorek A (2006) Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254–1264
Wang L, Li Y, Chen X, Chen J, Gautam S, Xu Y, Chopp M (2002) MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7:113–117
Charalambous C, Pen L, Su Y, Milan J, Chen T, Hofman F (2005) Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res 65:10347–10354
Desbaillets I, Diserens A, de Tribolet N, Hamou M, Van Meir E (1999) Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18:1447–1456
Platten M, Wick W, Weller M (2001) Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52:401–410
Brat D, Bellail A, Van Meir E (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 7:122–133
Silva G, Litovsky S, Assad J, Sousa A, Martin B, Vela D, Coulter S, Lin J, Ober J, Vaughn W, Branco R, Oliveira E, He R, Geng Y, Willerson J, Perin E (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150–156
Li Y, Chen J, Zhang C, Wang L, Lu D, Katakowski M, Gao Q, Shen L, Zhang J, Lu M, Chopp M (2005) Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49:407–417
Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam S, Chopp M (2003) Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778–786
Tille J, Pepper M (2002) Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Exp Cell Res 280:179–191
Majumdar M, Banks V, Peluso D, Morris E (2000) Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 185:98–106
Reyes M, Verfaillie C (2001) Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann NY Acad Sci 938:231–233
Conget P, Minguell J (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67–73
De Ugarte D, Alfonso Z, Zuk P, Elbarbary A, Zhu M, Ashjian P, Benhaim P, Hedrick M, Fraser J (2003) Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 89:267–270
Acknowledgments
This work was supported by grants of the Förderprogramm für Forschung und Lehre, LMU Munich, Germany, and by grants of the Friedrich-Baur-Stiftung, Munich, Germany. Parts of this work are elements of one co-author´s dissertation (Julia Roider) presented to the Medical Faculty, LMU Munich, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Birnbaum, T., Roider, J., Schankin, C.J. et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 83, 241–247 (2007). https://doi.org/10.1007/s11060-007-9332-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9332-4